MENU

Gruppo Bianchini

Name of Research Team/Laboratory: 

Laboratorio di Medicina Traslazionale (Translational Research Laboratory)

 

Coordinator Dr. Francesca Bianchini PhD

 

Brief Biographical sketch of the Coordinator:

Dr Bianchini has expertise in Experimental Pathology, Molecular Biology, Medicinal Chemistry and in vivo Preclinical Models of Cancer. Since graduation in Biological Science, Dr Bianchini has focused her research activity on the role of the interactions between host cells an cancer cells in the tumoral microenvironment that lead to the promotion of neoplastic growth and metastatic diffusion.

 

Member of the Scientific Board the Doctorate/PhD Program in: Dottorato in Scienze Biomediche

Member of the following Scientific Societies:

SIPMeT: Società Italiana di Patologia e Medicina Traslazionale

SIC: Società Italiana di Cancerologia

Member of editorial board of the following Journals

 

Research Team

Noemi Monaco 02/08/1995

 

Current research interest

Dr Bianchini developed high level of specialization on the role of integrin receptors in different diseases. Currently, the focus of her research activity includes, but is not limited to:

Development and biological characterization of Arg-Gly-Asp (RGD) integrin antagonist as tools for targeted drug delivery

RGD antagonists as tools for non-invasive medical imaging.

Role of tumor microenvironment factors (pH, pO2, Glucose and Glutamine) in cancer progression.

Nanomedicine and personalized cell-therapy

 

Key words: Medicinal Chemistry, Preclinical Imaging, Tumor stroma Interactions

 

Current/recent sources of funding:

Ente Cassa di Risparmio di Firenze: Sintesi di nuovi agenti anti-fibrotici per il trattamento della Fibrosi Polmonare Idiopatica

Progetto per Ricercatori a Tempo Determinato (RTD) dell’Università di Firenze 2020-2021: Cancer-induced bone pain in a murine model of breast carcinoma: role Transient Receptor Potential channels

 

10 best pubblications of the last 5 years:

 

Andreucci, E., Peppicelli, S., Ruzzolini, J., Bianchini, F., Biagioni, A., Papucci, L., Magnelli, L., Mazzanti, B., Stecca, B., Calorini, L. The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells (2020) Journal of Molecular Medicine, 98 (10), pp. 1431-1446. DOI: 10.1007/s00109-020-01959-y

 

Calvani, M., Bruno, G., Dabraio, A., Subbiani, A., Bianchini, F., Fontani, F., Casazza, G., Vignoli, M., De Logu, F., Frenos, S., Filippi, L., Favre, C. β3-Adrenoreceptor Blockade Induces Stem Cells Differentiation in Melanoma Microenvironment (2020) International Journal of Molecular Sciences, 21 (4), art. no. 1420 DOI: 10.3390/ijms21041420

 

Peppicelli, S., Andreucci, E., Ruzzolini, J., Bianchini, F., Calorini, L. FDG uptake in cancer: A continuing debate (2020) Theranostics, 10 (7), pp. 2944-2948. DOI: 10.7150/thno.40599

 

Bianchini, F., De Santis, A., Portioli, E., Russo Krauss, I., Battistini, L., Curti, C., Peppicelli, S., Calorini, L., D'Errico, G., Zanardi, F., Sartori, A. Integrin-targeted AmpRGD sunitinib liposomes as integrated antiangiogenic tools (2019) Nanomedicine: Nanotechnology, Biology, and Medicine, 18, pp. 135-145. DOI: 10.1016/j.nano.2019.02.015

 

Bianchini, F., Portioli, E., Ferlenghi, F., Vacondio, F., Andreucci, E., Biagioni, A., Ruzzolini, J., Peppicelli, S., Lulli, M., Calorini, L., Battistini, L., Zanardi, F., Sartori, A. Cell-targeted c(AmpRGD)-sunitinib molecular conjugates impair tumor growth of melanoma (2019) Cancer Letters, 446, pp. 25-37. DOI: 10.1016/j.canlet.2018.12.021

 

Maggi, V., Bianchini, F., Portioli, E., Peppicelli, S., Lulli, M., Bani, D., Sole, R.D., Zanardi, F., Sartori, A., Fiammengo, R.  Gold Nanoparticles Functionalized with RGD-Semipeptides: A Simple yet Highly Effective Targeting System for αVβ3 Integrins (2018) Chemistry - A European Journal, 24 (46), pp. 12093-12100.  DOI: 10.1002/chem.201801823

 

Sartori, A., Portioli, E., Battistini, L., Calorini, L., Pupi, A., Vacondio, F., Arosio, D., Bianchini, F., Zanardi, F. Synthesis of Novel c(AmpRGD)-Sunitinib Dual Conjugates as Molecular Tools Targeting the αvβ3 Integrin/VEGFR2 Couple and Impairing Tumor-Associated Angiogenesis

(2017) Journal of Medicinal Chemistry, 60 (1), pp. 248-262.  DOI: 10.1021/acs.jmedchem.6b01266

 

Bianchini, F., Peppicelli, S., Fabbrizzi, P., Biagioni, A., Mazzanti, B., Menchi, G., Calorini, L., Pupi, A., Trabocchi, A. Triazole RGD antagonist reverts TGFβ1-induced endothelial-to-mesenchymal transition in endothelial precursor cells (2017) Molecular and Cellular Biochemistry, 424 (1-2), pp. 99-110.  DOI: 10.1007/s11010-016-2847-2

 

Bianchini, F., Fabbrizzi, P., Menchi, G., Raspanti, S., Bottoncetti, A., Passeri, A., Andreucci, E., Guarna, A., Calorini, L., Pupi, A., Trabocchi, A. Radiosynthesis and micro-SPECT analysis of triazole-based RGD integrin ligands as non-peptide molecular imaging probes for angiogenesis

(2015) Bioorganic and Medicinal Chemistry, 23 (5), pp. 1112-1122.

DOI: 10.1016/j.bmc.2014.12.065

 

Sartori, A., Bianchini, F., Migliari, S., Burreddu, P., Curti, C., Vacondio, F., Arosio, D., Ruffini, L., Rassu, G., Calorini, L., Pupi, A., Zanardi, F., Battistini, L. Synthesis and preclinical evaluation of a novel, selective 111In-labelled aminoproline-RGD-peptide for non-invasive melanoma tumor imaging (2015) MedChemComm, 6 (12), pp. 2175-2183.

 

Previous research experiences:

Prof. Charles N. Serhan at the Brigham&Women’s Hospital, Harvard Medical School, Boston (MA) US. Role of lipid mediators, derived from the omega-6 and omega-3 poly-unsaturated fatty acids, in the regulation of inflammatory response and resolution of inflammation.

 

Collaborations:

 

Prof.ssa Franca Zanardi, Università di Parma – Dipartimento di Scienze degli Alimenti e del Farmaco

Prof. Andrea Sartori, Università di Parma– Dipartimento di Scienze degli Alimenti e del Farmaco

Prof. Andrea Trabocchi, Università di Firenze – Dipartimento di Chimica

Prof. Roberto Fiammengo, Università di Verona – Dipartimento di Biotecnologie

Prof.ssa Vasiliki Sarli, Aristotle University of Thessaloniki, Chemistry Department.

 

Dipartimenti aderenti oltre al DSBSC UNIFI:

CISPIM, centro Interdipartimentale per lo Sviluppo Preclinico dell’Imaging Molecolare

 

Ultimo aggiornamento

01.12.2021

Cookie

I cookie di questo sito servono al suo corretto funzionamento e non raccolgono alcuna tua informazione personale. Se navighi su di esso accetti la loro presenza.  Maggiori informazioni